Literature DB >> 27128390

Motor Control Exercise for Nonspecific Low Back Pain: A Cochrane Review.

Bruno T Saragiotto1, Christopher G Maher1, Tiê P Yamato1, Leonardo O P Costa2, Luciola C Menezes Costa2, Raymond W J G Ostelo3,4, Luciana G Macedo5.   

Abstract

STUDY
DESIGN: A systematic review.
OBJECTIVE: The aim of this review was to evaluate the effectiveness of motor control exercise (MCE) in patients with nonspecific low back pain (LBP). SUMMARY OF BACKGROUND DATA: MCE is a common form of exercise used for managing LBP. MCE focuses on the activation of the deep trunk muscles and targets the restoration of control and coordination of these muscles, progressing to more complex and functional tasks integrating the activation of deep and global trunk muscles.
METHODS: We conducted electronic searches of CENTRAL, MEDLINE, EMBASE, five other databases, and two trials registers from their inception up to April 2015. Two independent review authors screened the search results, assessed risk of bias, and extracted the data. A third reviewer resolved any disagreement. We included randomized controlled trials comparing MCE with no treatment, another treatment, or as a supplement to other interventions in patients with nonspecific LBP. Primary outcomes were pain intensity and disability. We assessed risk of bias using the Cochrane Back and Neck (CBN) Review Group 12-item criteria. We combined results in a meta-analysis expressed as mean difference and 95% confidence interval. We assessed the overall quality of the evidence using the GRADE approach.
RESULTS: We included 32 trials (n = 2628). Most included trials had a low risk of bias. For acute LBP, low to moderate quality evidence indicates no clinically important differences between MCE and spinal manipulative therapy or other forms of exercise. There is very low-quality evidence that the addition of MCE to medical management does not provide clinically important improvements. For recurrence at one year, there is very low-quality evidence that MCE and medical management decrease the risk of recurrence. For chronic LBP, there is low to moderate quality evidence that MCE is effective for reducing pain compared with minimal intervention. There is low to high-quality evidence that MCE is not clinically more effective than other exercises or manual therapy. There is very low to low quality evidence that MCE is clinically more effective than exercise and electrophysical agents (EPAs) or telerehabilitation for pain and disability.
CONCLUSION: MCE is probably more effective than a minimal intervention for reducing pain, but probably does not have an important effect on disability, in patients with chronic LBP. There was no clinically important difference between MCE and other forms of exercises or manual therapy for acute and chronic LBP. LEVEL OF EVIDENCE: 1.

Entities:  

Mesh:

Year:  2016        PMID: 27128390     DOI: 10.1097/BRS.0000000000001645

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  34 in total

Review 1.  Factors associated with the reporting quality of low back pain systematic review abstracts in physical therapy: a methodological study.

Authors:  Dafne Port Nascimento; Gabrielle Zoldan Gonzalez; Amanda Costa Araujo; Anne Moseley; Christopher Maher; Leonardo Oliveira Pena Costa
Journal:  Braz J Phys Ther       Date:  2020-11-11       Impact factor: 3.377

2.  Developing clinical procedures to diagnose specific motor control impairments associated with low back pain: prone hip extension (PHE), active straight leg raise (ASLR), and gait variability.

Authors:  Paul Bruno
Journal:  J Can Chiropr Assoc       Date:  2017-12

3.  Alternating lumbar lateral shift: a case report.

Authors:  Seth Peterson; Mark Laslett
Journal:  J Man Manip Ther       Date:  2020-07-02

4.  Predicting a beneficial response to motor control training in patients with low back pain: a longitudinal cohort study.

Authors:  Julie A Hides; Michael Murphy; Ellen Jang; Linda Blackwell; Margot Sexton; Christopher Sexton; M Dilani Mendis
Journal:  Eur Spine J       Date:  2019-06-27       Impact factor: 3.134

5.  Development of a Clinical Decision Aid for Chiropractic Management of Common Conditions Causing Low Back Pain in Veterans: Results of a Consensus Process.

Authors:  Robert D Vining; Zacariah K Shannon; Stacie A Salsbury; Lance Corber; Amy L Minkalis; Christine M Goertz
Journal:  J Manipulative Physiol Ther       Date:  2019-12-19       Impact factor: 1.437

6.  Impact of exercise programs among helicopter pilots with transient LBP.

Authors:  Knut Andersen; Roald Baardsen; Ingvild Dalen; Jan Petter Larsen
Journal:  BMC Musculoskelet Disord       Date:  2017-06-20       Impact factor: 2.362

7.  Safety and feasibility of transcranial direct current stimulation (tDCS) combined with sensorimotor retraining in chronic low back pain: a protocol for a pilot randomised controlled trial.

Authors:  Adam Louis Ouellette; Matthew B Liston; Wei-Ju Chang; David M Walton; Benedict Martin Wand; Siobhan M Schabrun
Journal:  BMJ Open       Date:  2017-08-21       Impact factor: 2.692

8.  Optimising conservative management of chronic low back pain: study protocol for a randomised controlled trial.

Authors:  Katherine J Simson; Clint T Miller; Jon Ford; Andrew Hahne; Luana Main; Timo Rantalainen; Wei-Peng Teo; Megan Teychenne; David Connell; Guy Trudel; Guoyan Zheng; Gary Thickbroom; Daniel L Belavy
Journal:  Trials       Date:  2017-04-20       Impact factor: 2.279

9.  An Integrative Neuroscience Framework for the Treatment of Chronic Pain: From Cellular Alterations to Behavior.

Authors:  Jess D Greenwald; Keith M Shafritz
Journal:  Front Integr Neurosci       Date:  2018-05-23

10.  Combined neuromuscular electrical stimulation with motor control exercise can improve lumbar multifidus activation in individuals with recurrent low back pain.

Authors:  Sranya Songjaroen; Panakorn Sungnak; Pagamas Piriyaprasarth; Hsing-Kuo Wang; James J Laskin; Peemongkon Wattananon
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.